Beitnere_2014_Eur.J.Pharmacol_745_76

Reference

Title : Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats - Beitnere_2014_Eur.J.Pharmacol_745_76
Author(s) : Beitnere U , Dzirkale Z , Isajevs S , Rumaks J , Svirskis S , Klusa V
Ref : European Journal of Pharmacology , 745 :76 , 2014
Abstract :

The present study investigates the efficacy of mildronate, a carnitine congener, to protect stress and haloperidol-induced impairment of memory in rats and the expression of brain protein biomarkers involved in synaptic plasticity, such as brain-derived neurotrophic factor (BDNF), acetylcholine esterase and glutamate decarboxylase 67 (GAD67). Two amnesia models were used: 2h immobilization stress and 3-week haloperidol treatment. Stress caused memory impairment in the passive avoidance test and induced a significant 2-fold BDNF elevation in hippocampal and striatal tissues that was completely inhibited by mildronate. Mildronate decreased the level of GAD67 (but not acetylcholine esterase) expression by stress. Haloperidol decrease by a third hippocampal BDNF and acetylcholine esterase (but not GAD67) expression, which was normalized by mildronate; it also reversed the haloperidol-induced memory impairment in Barnes test. The results suggest the usefulness of mildronate as protector against neuronal disturbances caused by stress or haloperidol.

PubMedSearch : Beitnere_2014_Eur.J.Pharmacol_745_76
PubMedID: 25446926

Related information

Citations formats

Beitnere U, Dzirkale Z, Isajevs S, Rumaks J, Svirskis S, Klusa V (2014)
Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats
European Journal of Pharmacology 745 :76

Beitnere U, Dzirkale Z, Isajevs S, Rumaks J, Svirskis S, Klusa V (2014)
European Journal of Pharmacology 745 :76